Skip to main content
SpringerLink
Log in

Alte und neue Antidepressiva

  • Chapter
Die therapeutische Vielfalt in der Depressionsbehandlung

  • 65 Accesses

Zusammenfassung

Dieser Beitrag fokussiert trotz seiner Überschrift auf die „neuen“ Antidepressiva. Dennoch sollen für den fachfremden Leser hier auch die wichtigsten Punkte zu den klassischen Antidepressiva kurz zusammengefasst werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Angst J, Baumann M, Hippius H, Rothweiler R (1974) Clinical aspects of resistance to imipramine therapy. Pharmakopsychiat 7: 211–216

    Article  CAS  Google Scholar 

  • Ansseau M, Darimont P, Lecoq A et al. (1994) Controlled comparison of Nefazodone and Amitriptyline in major depressive inpatients. Psychopharmacology 115: 254–260

    Article  PubMed  CAS  Google Scholar 

  • Baldwin D, Rudge S (1994) Tolerability of Moclobemide. Rev Contemp Pharmacother 5: 57–65

    Google Scholar 

  • Ban TA, Graszner P, Aguglia E et al. (1998) Clinical efficacy of reboxetine: A comparative study with desipramine, with methological considerations. Human Psychopharmacol 13: 29–39

    Article  Google Scholar 

  • Beckmann H (1981) Pharmacological treatment of affective disorders. Nervenarzt 52: 135–146

    PubMed  CAS  Google Scholar 

  • Berzewski H, Van Moffaert M, Gagiano CA (1997) Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes. Eur Neuropsychopharmacol 7 [Suppl 1]: 37–47

    Article  Google Scholar 

  • Bolden-Watson C, Richelson E (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52 (12): 1023–1029

    Article  PubMed  CAS  Google Scholar 

  • Boudriot S (2001) Wirksamkeitsnachweis in klinischen Studien: Vergleich der neueren Antidepressiva Reboxetin, Nefazodon and Mirtazapin. Inaugural-Dissertation. Medizinische Fakultät der Eberhard-Karls-Universität Tübingen

    Google Scholar 

  • Bremner JD, Smith WT (1996) ORG 3770 VS Amitriptyline in the continuation treatment of depression: A placebo controlled trial. Eur J Psychiat 10: 5–15

    Google Scholar 

  • Breyer-Pfaff U, Gaertner HJ (1987) Antidepressiva. Pharmakologie, therapeutischer Einsatz and Klinik der Depression. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Bruijn JA, Moleman P, Mulder PGH, Van den Broek WW, Van Hulst AM, Van der Mast RC, Van de Wetering BJM (1996) A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology 127: 231–237

    Article  PubMed  CAS  Google Scholar 

  • Burrows GD, Maguire KP, Norman TR (1998) Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor Reboxetine: A review. J Clin Psychiatry 59 [Suppl 14]: 4–7

    Google Scholar 

  • Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 (14): 1010–1015

    Article  PubMed  CAS  Google Scholar 

  • Claghorn JL, Lesem MD (1995) A double-blind placebo-controlled study of org 3770 in depressed patients. J Affect Disorders 34: 165–171

    Article  PubMed  CAS  Google Scholar 

  • Clerc GE, Ruimy P, Verdeau-Palles J (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 9: 139–143

    Article  PubMed  CAS  Google Scholar 

  • Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF (1995) Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 152 (11): 1641–1645

    PubMed  CAS  Google Scholar 

  • D’Amico MF, Roberts DL, Robinson DS, Schwiederski UE, Copp J (1990) Placebo-controlled dose-ranging trial designs in phase II developement of nefazodone. Psychopharmacol Bull 26: 147–150

    PubMed  Google Scholar 

  • Ellingrod VL, Perry PJ (1995) Nefazodone a new antidepressant. Am J Health-Syst Pharm 52: 2799–2812

    PubMed  CAS  Google Scholar 

  • Entsuah AR, Rudolph RL, Hackett D et al. (1996) Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates. Int Clin Psychopharmacol 11: 137–45

    PubMed  CAS  Google Scholar 

  • Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS (1996) Nefazodone versus sertaline in outpatients with major depression: Focus on efficacy, tolerability and effects on sexual function and satisfaction. J Clin Psychiatry 57 [Suppl]: 53–62

    PubMed  CAS  Google Scholar 

  • Feighner JP, Pambakian R, Fowler RC, Boyer WF, D’Amico MF (1989) A comparison of nefazodone, imipramine and placebo in patients with moderate to severe depression. Psychopharmacol Bull 25: 219–221

    PubMed  CAS  Google Scholar 

  • Ferrier IN (1999) Treatment of major depression: Is improvement enough? J Clin Psychiatry 60 [Suppl 6]: 10–14

    Google Scholar 

  • Gillin JC, Rapaport M, Erman MK et al. (1997) A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-ratedd measures of sleep in depressed patients: a double-blind, 8-week clinical trial. J Clin Psychiatry 58: 185–92

    Article  PubMed  CAS  Google Scholar 

  • Gleiter ChH, Volz HP, Möller HJ (1999) Serotonin-Wiederaufnahmehemmer. Pharmakologie and therapeutischer Einsatz. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Halikas JA (1995) Org 3770 (Mirtazapine) versus Trazodone: A placebo controlled trial in depressed elderly patients. Human Psychopharmacol 10: S215–S133

    Google Scholar 

  • Hoyberg OJ,Maragakis B, Mullin J (1996) A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychiatr Scand 93: 184–90

    Article  Google Scholar 

  • Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (CSSRIs). Int Clin Psychopharmacol 9 Suppl 1: 19–26

    Article  Google Scholar 

  • Kasper S, Praschak-Rieder N, Tauscher J et al. (1997) A risk-benefit assessment of mirtazapine in the treatment of depression. Drug Saf 17: 251–64

    Article  PubMed  CAS  Google Scholar 

  • Kasper S (1995) Clinical efficacy of mirtazapine: a review of meta-analysis of pooled data. Int Clin Psychopharmacol 10 [Suppl 4]: 25–35

    Article  PubMed  Google Scholar 

  • Kent J (2000) SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 355: 911

    Article  PubMed  CAS  Google Scholar 

  • Massana J, Möller H-J, Burrows GD, Montenegro RM (1999) Reboxetine: A double-blind comparison with fluoxetine in major depressive disorder. International Clinical Psychopharmacology 14: 73–80

    Article  PubMed  CAS  Google Scholar 

  • Montgomery SA, Reimitz PE, Zivkov M (1998) Mirtazapine versus amitriptyline in a long-term treatment od depression: a double-blind, placebo-controlled study. Int Clin Psychopharmacol 18: 63–73

    Article  Google Scholar 

  • Montgomery SA (1997) Is there a role for a pure noradrenergic drug in the treatment of depression? European Neuropsychopharmacology 7 [Suppl]: 3–9

    Article  Google Scholar 

  • Montgomery SA (1998) Chairman’s overview. The place of Reboxetne in antidepressant therapy. J Clin Psychiatry 59 [Suppl]: 26–29

    PubMed  Google Scholar 

  • Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, Kuhn N, Koren G (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336 (4): 258–262

    Article  PubMed  CAS  Google Scholar 

  • Reynaert C, Janne P, Zdanowicz N mit der Venlafaxine 600A-GAP-BE Study Group (2000) Cliniques Universitaires de Montgodinne, Yvoir, Belgium, Wyeth Lederle Belgium, Louvain-la Neuve, Belgium. Poster. 13. ECNP Kongress, München 9.-13. 9. 2000

    Google Scholar 

  • Schmauss M, Kapfhammer HP, Meyr P, Hoff P (1988) Combined MAO-inhibitor and tri- (tetra) cyclic antidepressant treatment in therapy resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 12 (4): 523–532

    Article  PubMed  CAS  Google Scholar 

  • Smith WT, Glaudin V, Panagides J, Gilvary E (1990) Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Psychopharmacology Bull 26: 191–196

    CAS  Google Scholar 

  • Thase ME (1997) Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression: the Venlafaxine XR 209 Study Group. J Clin Psychiatry 14: 392–398

    Google Scholar 

  • Versiani M, Amin M, Chouinard G (2000) Double-blind, placebo-controlled study with Reboxe- tine in inpatients with severe major depressive disorder. J Clin Psychopharmacol 20: 28–34

    Article  PubMed  CAS  Google Scholar 

  • Versiani M, Mehilane L, Graszner P, Arnaud-Castiglioni R (1999) Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term-treatment of major depressive disorder. J Clin Psychiatry 60 (6): 400–406

    Article  PubMed  CAS  Google Scholar 

  • Wheatly DP, Van Moffaert M, Timmerman L, Kremer ME (1998) Mirtazapine: Efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive Disorder. J Clin Psychiatry 59: 306–312

    Article  Google Scholar 

Download references

Authors
  1. H. J. Gaertner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Boudriot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Gaertner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinik für Psychiatrie und Psychotherapie, Osianderstr. 24, 72076, Tübingen, Deutschland

    A. Batra  & G. Buchkremer  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gaertner, H.J., Boudriot, S., Gaertner, I. (2001). Alte und neue Antidepressiva. In: Batra, A., Buchkremer, G. (eds) Die therapeutische Vielfalt in der Depressionsbehandlung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59494-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59494-6_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42072-9

  • Online ISBN: 978-3-642-59494-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation